Answers are grounded in this paper and cite their sources.
Alzheimer's Disease (AD) is characterized by deposition of Amyloid-Beta Peptide (A), which is produced from post-translational processing of Amyloid Precursor Protein (APP). The goal of this short review is to outline the major aspects of the biology of APP and the importance of APP in Alzheimer's Disease. Subsequently, we briefly review current concepts regarding the potential targeting of APP processing in order to influence the ramifications of AD. Studies are underway to assess methods of altering the regulation of the APP gene as well as the regulation of the post-translational processing of APP. The complexity of APP processing has made the identification of new treatments for AD difficult. Future methods of targeting APP processing and expression are discussed.
No takes yet. Share an insight, caveat, or question.
Andrew B. Bonner (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: